heparin/stroke

Lyen an sove nan clipboard la

Chwazi kalite sòt

Paj 1 soti nan 2375 rezilta yo

Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND The risk of intracerebral hemorrhage in systemic thrombolysis for acute ischemic stroke after acetylsalicylic acid (ASA) pretreatment or with subsequent heparin is controversially discussed. METHODS 300 consecutive stroke patients were treated with recombinant tissue-type plasminogen

Reduced Ischemic Lesion Growth with Heparin in Acute Ischemic Stroke.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The role of heparin in acute ischemic stroke is controversial. We investigated the effect of heparin on ischemic lesion growth.Data were analyzed on nonthrombolyzed ischemic stroke patients in whom diffusion-weighted imaging (DWI)/perfusion-weighted imaging

Intravenous heparin for the treatment of intraluminal thrombus in patients with acute ischemic stroke: a case series.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

OBJECTIVE Current American Stroke Association/American Heart Association recommendations on the management of acute ischemic stroke do not recommend the early use of heparin because of an increased risk of bleeding complications. However, for select patients, such as those with strokes associated

Use of Heparin in Acute Ischemic Stroke: Is There Still a Role?

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Heparin has long been a contested therapy in acute ischemic stroke (AIS). In current practice, heparin is considered on a case-by-case basis, but there is no consensus as to the appropriate timing of anticoagulation or for which ischemic stroke subtypes heparin may be beneficial. To provide better

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Low molecular weight heparins and heparinoids may be associated with lower risks of haemorrhage and more powerful antithrombotic effects than standard unfractionated heparin. OBJECTIVE The objective of this review was to compare the effects of low molecular weight heparins or heparinoids

Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The numerous large-scale randomized clinical trials performed during the last decade on either unfractionated heparin, or low molecular weight heparin have not been able to demonstrate undisputed benefits in patients with acute ischemic stroke, compared with no treatment or aspirin. However, a large

Symptomatic intracerebral hematomas in posterior circulation stroke patients anticoagulated with heparin.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND A lot of clinicians use heparin in patients with posterior circulation stroke. Frequency and risk factors of symptomatic intracerebral hematoma (ICH) in posterior circulation infarct patients anticoagulated with unfractionated heparin are not known. METHODS To determine the incidence and

[Ischemic stroke and heparin-induced thrombocytopenia].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Immune-mediated heparin-induced thrombocytopenia (HIT) is a rare but serious side effect of heparin therapy which presents various thromboembolic events associated with high mortality and morbidity. There have been few reports about the prevalence of HIT in acute ischemic stroke, which our

[Heparin and ischemic stroke].

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

In absence of careful controlled trials, heparin therapy of ischemic stroke is based today on the clinical experience and personal belief of the physicians. Moreover, the incomplete knowledge of physiopathogenesis of ischemic stroke adds further confusion on those nosographic conditions treatable

Aspirin or heparin in acute stroke.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Acute stroke treatment using aspirin and/or heparin was studied in the International Stroke Trial (IST) and Chinese Acute Stroke Trial (CAST) which randomised over 40,000 patients altogether. Combining the results demonstrated that aspirin (150-300 mg) given within 48 h of the onset of stroke

Subcutaneous Heparin Therapy for Patients with Cancer-Associated Stroke.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

BACKGROUND Anticoagulation therapy, particularly subcutaneous heparin therapy, is recommended for cancer-associated thrombosis. However, not starting or discontinuing anticoagulation was not rare. The aim of the present study was to examine the practical issues related to anticoagulation therapy and

Heparin during endovascular stroke treatment seems safe.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

the effect of intravenous heparin during mechanical thrombectomy for acute ischemic stroke is not clear. We aimed to study efficacy and safety of heparin use during endovascular stroke treatment in a real-world setting.patients with anterior circulation

Heparin in acute ischemic stroke revisited.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

The evidence gathered in clinical trials of low molecular weight heparins (LMWHs) or with unfractionated heparin (UH) given subcutaneously at low or medium doses to patients with acute stroke cannot be extrapolated to the insufficiently tested effects of intravenous, weight-adjusted UH. Recent small

Acute ischemic stroke and heparin treatments.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Several case-control studies have reported enhanced platelet activity, hypercoagulation and/or reduced fibrinolytic activity in patients with acute ischemic stroke. However, results of these studies are conflicting and do not allow to make recommendations regarding heparin treatment. The aim of

Antre nan paj
facebook nou an

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye